<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Conmed Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/conmed-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611</link>
		<comments>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611#comments</comments>
		<pubDate>Tue, 20 Mar 2012 02:13:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94611</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/19/mdt-medtech-industry-stock-outlook-march-2012-zacks-analyst-interviews/94611/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) MedTech Industry Stock Outlook &#8211; March 2012 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609</link>
		<comments>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609#comments</comments>
		<pubDate>Thu, 08 Mar 2012 19:28:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94609</guid>
		<description><![CDATA[Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure volume pressures. The difficult macroeconomic backdrop, pricing headwinds, austerity measures, reimbursement pressure, a still unstable job market and the impact of health care reform continue to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. With fewer patients going under the knife accompanied by concerns of overuse of devices, companies in the cardiovascular and orthopedic domain continue to grapple with tepid utilization. After having a buoyant first half, the MedTech sector went through a rough patch in the back half of 2011 given the weakened sector fundamentals, sluggish key end-markets ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/08/mdt-medtech-industry-stock-outlook-march-2012-industry-outlook/94609/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Technology Industry Stock Outlook &#8211; November 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069</link>
		<comments>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069#comments</comments>
		<pubDate>Fri, 18 Nov 2011 18:52:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[THOR]]></category>
		<category><![CDATA[Thoratec Corporation]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87069</guid>
		<description><![CDATA[The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures, reimbursement pressure and the impact of health care reform continues to weigh on the medical devices industry, exacerbated by Europe&#8217;s sovereign debt plight. The beleaguered U.S. implantable defibrillator market continues to bother cardiac devices makers, as reflected by sustained implant volume pressure. On the other hand, companies in the orthopedic domain remain affected by a still choppy reconstructive implant market as they faced sustained pressure across hip, knee and spine businesses in the third quarter (albeit to a lesser extent vis-à-vis the sequentially prior quarter). Although a number of these issues are ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/18/mdt-medical-technology-industry-stock-outlook-november-2011-industry-outlook/87069/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic&#8217;s Third Quarter Mixed &#8211; View Lowered</title>
		<link>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151</link>
		<comments>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151#comments</comments>
		<pubDate>Fri, 04 Nov 2011 18:40:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86151</guid>
		<description><![CDATA[Orthotic and prosthetic (O&#38;P) company Hanger Orthopedic’s (HGR) third-quarter fiscal 2011 adjusted earnings of 46 cents a share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago adjusted earnings of 37 cents. The adjusted earnings exclude the costs associated with acquisitions and the relocation of the company’s corporate headquarters from Bethesda, Maryland, to Austin, Texas. Profit (as reported) more than doubled year over year to $15.4 million (or 45 cents a share), powered by a double-digit expansion in sales. The year ago quarter’s profit was hit by a hefty (roughly $8 million) relocation charge. Hanger recorded modest relocation expenses in the third quarter. Revenues &#38; Margins Net sales surged 13.8% year over year to $235.3 million, just missing the Zacks Consensus Estimate of $236 million. Revenue growth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/04/hgr-hanger-orthopedics-third-quarter-mixed-view-lowered/86151/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; Sept. 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743</link>
		<comments>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743#comments</comments>
		<pubDate>Thu, 08 Sep 2011 19:53:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82743</guid>
		<description><![CDATA[June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected to linger over the second-half of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The highly-regulated medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/08/mdt-medical-devices-stock-outlook-sept-2011-industry-outlook/82743/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Meets The Strret But Costs Hurt</title>
		<link>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498</link>
		<comments>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498#comments</comments>
		<pubDate>Mon, 08 Aug 2011 17:40:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=79498</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) posted second-quarter fiscal 2011 adjusted earnings per share of 90 cents, meeting the Zacks Consensus Estimate while transcending the year-agoearnings of 80 cents. Adjusted net income jumped 10.4% year over year to $352 million. The adjusted earnings exclude $43 million in charges associated with the company’s recent buyout of its rival Orthovita and the $1.5 billion acquisition of Boston Scientific’s (BSX) Neurovascular business. However, profit (as reported) skid 3.1% to $309 million (or 79 cents a share) on account of the sizable acquisition-related charges. Stryker is on an acquisition binge to spur growth as its faces sustained pricing and procedure volume pressure in its core replacement hips and knees businesses. However, costs associated with such transactionshave weighed on its bottom line. The Kalamazoo, Michigan-based ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/08/syk-stryker-meets-the-strret-but-costs-hurt/79498/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Outlook &#8211; June 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179</link>
		<comments>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179#comments</comments>
		<pubDate>Thu, 23 Jun 2011 01:09:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[Sprint Nextel Corporation]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77179</guid>
		<description><![CDATA[A host of macro headwinds (including price and procedure volume pressure) which hit the MedTech industry last year continued to haunt the sector during the March quarter and encumber growth. Although a number of these issues are expected to linger through the remainder of 2011, the industry is expected to fare relatively better this year thanks to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments including Cardiology, Oncology, Neuro, Orthopedic and Aesthetic Devices. The U.S. medical devices industry continues to grow at a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/22/mdt-medical-devices-stock-outlook-june-2011-industry-outlook/77179/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Adopts NextGen Healthcare Solutions</title>
		<link>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599</link>
		<comments>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599#comments</comments>
		<pubDate>Thu, 16 Jun 2011 21:57:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76599</guid>
		<description><![CDATA[Leading orthotic and prosthetic (O&#38;P) company Hanger Orthopedic (HGR) has partnered with NextGen Healthcare, the wholly-owned subsidiary of Quality Systems’ (QSII). Under the collaboration, Hanger will implement NextGen’s Ambulatory electronic health record (“EHR”) and Practice Management solutions to automate clinical and operational workflows (such as medical records, billing and scheduling) across hundreds of patient care centers. NextGen’s integrated Ambulatory Practice Management and EHR products enable coordination of patient care with formalized clinical and administrative workflows in any health care facility. Moreover, the company’s in-patient products such as NextGen Financials and NextGen Clinicals have extended its services to community and rural hospitals. Hanger leads in the O&#38;P patient care services market, operating through more than 675 patient care centers across the U.S. The company is enjoying healthy demand for its services. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/16/hgr-hanger-orthopedic-adopts-nextgen-healthcare-solutions/76599/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Analyst Maintains Outperform on Shares</title>
		<link>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198</link>
		<comments>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198#comments</comments>
		<pubDate>Mon, 06 Jun 2011 04:11:14 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74198</guid>
		<description><![CDATA[We reaffirm our Outperform rating on orthotic and prosthetic (O&#38;P) company Hanger Orthopedic (HGR)  as we remain upbeat about its business prospects. Earnings for first-quarter fiscal 2011 matched the Zacks Consensus Estimate while profit skyrocketed 55% year over year owing to the combined impact of higher revenues and management’s cost containment initiatives. Healthy contributions from the company’s therapeutic solutions and distribution businesses coupled with the acquisition of rehabilitation technologies provider Accelerated Care Plus (“ACP”) fueled double-digit growth in the top line. However, sales missed the Zacks Consensus Estimate. Hanger’s patient care business was negatively impacted by inclement weather. The company raised its earnings forecast for fiscal 2011 while maintaining its sales expectation for the year. Moreover, it remains optimistic about the growth prospects in its patient care business for the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/05/hgr-hanger-orthopedic-analyst-maintains-outperform-on-shares/74198/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed Beats The Street &#8211; Profit Jumps</title>
		<link>http://www.stockbloghub.com/2011/05/03/cnmd-conmed-beats-the-street-profit-jumps/73042</link>
		<comments>http://www.stockbloghub.com/2011/05/03/cnmd-conmed-beats-the-street-profit-jumps/73042#comments</comments>
		<pubDate>Tue, 03 May 2011 18:05:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73042</guid>
		<description><![CDATA[Conmed Corporation (CNMD) reported first-quarter fiscal 2011 adjusted (excluding one-time items such as restructuring charges) earnings per share of 37 cents, outpacing the Zacks Consensus Estimate of 30 cents and the year-ago adjusted earnings of 28 cents. Profit (as reported) for the quarter surged 23% year over year to roughly $9 million (or 31 cents a share) on account of higher revenues. Restructuring costs include expenses related to the consolidation of administrative functions and costs of transferring additional product lines to the company’s new manufacturing plant in Chihuahua, Mexico. Costs associated with these activities were $1.4 million in the quarter and the company expects restructuring expenses of $3 million-$4 million for the full year. Revenues Revenues rose 4% year over year to roughly $183.5 million. Sales beat the Zacks Consensus ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/03/cnmd-conmed-beats-the-street-profit-jumps/73042/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker 2011 First Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878</link>
		<comments>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878#comments</comments>
		<pubDate>Mon, 02 May 2011 14:53:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72878</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) reported first-quarter fiscal 2011 adjusted (excluding one-time acquisition-related charges) earnings per share of 90 cents, beating the Zacks Consensus Estimate by a penny. The Quarter Revisited Profit (as reported) for the quarter slid 4.4% on account of a hefty charge associated with the company’s acquisition of Boston Scientific’s (BSX) neurovascular business. Revenues surged 12% year over year to $2.02 billion, ahead of the Zacks Consensus Estimate of $2 billion. Sales were boosted by sustained double-digit growth at the company’s surgical equipment unit (MedSurg) coupled with the acquisition of the neurovascular business, which offset the lingering softness in its reconstructive business. Revenues from the reconstructive business edged up 1.9% in the quarter. Stryker’s hips and trauma businesses posted growth in the quarter, partly offset by ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/02/syk-stryker-2011-first-quarter-earnings-scorecard/72878/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker First Quarter 2011 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773</link>
		<comments>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773#comments</comments>
		<pubDate>Tue, 19 Apr 2011 19:30:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71773</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) is expected to release its first-quarter fiscal 2011 results on Tuesday, April 19, after the closing bell. Although the Michigan-based company has not divulged any specific financial targets for the quarter, it expects foreign currency to favorably impact sales by roughly 0% to 1%. The current Zacks Consensus Estimate for first quarter is 89 cents, representing an estimated 11.55% year over year growth. With respect to earnings surprise, Stryker has posted three positive surprises in the preceding four quarters while it met the Zacks Consensus Estimate on one occasion. The company has produced an average positive earnings surprise of 3.26% over the last four quarters, implying that it has beaten the Zacks Consensus Estimate by that measure. Fourth-Quarter Revisited Stryker reported better-than-expected fourth-quarter fiscal ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/19/syk-stryker-first-quarter-2011-earnings-preview/71773/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook &#8211; April 2011 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413</link>
		<comments>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413#comments</comments>
		<pubDate>Thu, 31 Mar 2011 23:07:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Accuray Incorporated]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[ARAY]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[Flaherty & Crumrine Preferred Income Opportunity F]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[PFO]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[TOMO]]></category>
		<category><![CDATA[TomoTherapy Incorporated]]></category>
		<category><![CDATA[VAR]]></category>
		<category><![CDATA[Varian Medical Systems Inc]]></category>
		<category><![CDATA[VOLC]]></category>
		<category><![CDATA[Volcano Corporation]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70413</guid>
		<description><![CDATA[Last year was challenging for medical device companies given the exigent economic conditions and an uncertain healthcare environment. The MedTech industry was hit by several macro headwinds in 2010 including price/volume and utilization pressure and a more restrictive regulatory environment. Although a number of these issues remain, the industry is expected to fare better this year due to several tailwinds and growth opportunities. Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative, with estimated worldwide sales of more than $300 billion in 2011. The U.S. is the largest medical devices market, with estimated sales of roughly $95 billion in 2010. The medical devices industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/31/mdt-medical-devices-industry-outlook-april-2011-industry-outlook/70413/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker&#8217;s New Hip System Approved by FDA</title>
		<link>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952</link>
		<comments>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952#comments</comments>
		<pubDate>Tue, 15 Feb 2011 14:54:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66952</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) has secured the 510(k) approval from the U.S. Food and Drug Administration (“FDA”) for its MDM X3 (“Modular Dual Mobility”) mobile bearing hip system. The product represents an important addition to the Michigan-based company’s portfolio of next-generation hip replacement systems. The MDM X3 is Stryker’s third-generation dual mobility device designed to enable surgeons to offer the benefits of the company’s dual mobility technology to a greater patient population. The device’s launch has been based on the success of Stryker’s flagship mobile bearing product “ADM X3” hip system launched in early 2010. The ADM X3 hip system is a premium priced product and has been positioned as an alternative to Metal-on-Metal (“MOM”) hip resurfacing systems that are, based on recent studies, associated with the risk ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/15/syk-strykers-new-hip-system-approved-by-fda/66952/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Completes divestiture of OP-1 product franchise</title>
		<link>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602</link>
		<comments>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602#comments</comments>
		<pubDate>Wed, 09 Feb 2011 01:28:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66602</guid>
		<description><![CDATA[Stryker Corp (SYK) has completed the divestiture of its bone growth product franchise (the “OP-1” product line) to Tokyo-based optical, medical and communication equipment maker Olympus Corporation for $60 million. The transaction includes the Michigan-based company’s manufacturing plant in Lebanon, New Hampshire. Stryker forged a definitive agreement to jettison these assets in December 2010. The OP-1 product line includes OP-1 Implant and OP-1 Putty for use in orthopedic bone applications such as lumbar spine fusion and the treatment of long bone fractures. The active ingredient in these products is the OP-1 bone growth factor that induces the formation of new bone when implanted into a bone. OP-1 products (Implant and Putty) are currently approved in the U.S. under the Humanitarian Device Exemption (“HDE”) having provided treatment to roughly 40,000 patients ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/08/syk-stryker-completes-divestiture-of-op-1-product-franchise/66602/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Fourht Quarter Earnings Beat &#8211; Concerns Linger</title>
		<link>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798</link>
		<comments>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798#comments</comments>
		<pubDate>Thu, 27 Jan 2011 05:29:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65798</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted earnings per share of 93 cents exceeding the Zacks Consensus Estimate of 90 cents and the year-ago earnings of 82 cents. For fiscal 2010, adjusted earnings of $3.33 per share beat the Zacks Consensus Estimate of $3.31 and was ahead of the year-ago earnings of $2.95. The results were supported by higher sales owing to strong contribution from the Michigan-based company’s surgical equipment business. The adjusted earnings exclude the charges associated with the company’s divestiture of its bone growth product franchise (the “OP-1” product line) to Tokyo-based equipment maker Olympus Corporation. Stryker recorded an impairment charge of roughly $124 million ($77 million net of tax) in the fourth quarter to reflect an anticipated loss in connection ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/26/syk-stryker-fourht-quarter-earnings-beat-concerns-linger/65798/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Increases Quarterly Dividend</title>
		<link>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861</link>
		<comments>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861#comments</comments>
		<pubDate>Sun, 26 Dec 2010 03:42:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61861</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corp (SYK) has raised its quarterly dividend to 18 cents a share from 15 cents, representing a 20% hike. This lifts the annual dividend to 72 cents per share from the current payout of 60 cents and equates to a dividend yield of roughly 1.4%. The revised quarterly dividend is payable on Jan 31, 2011, to shareholders of record as on Dec 31, 2010. Moreover, the Michigan-based company’s Board has approved an additional $500 million share repurchase authorization, representing another commitment to boost shareholder returns. The repurchase will be executed from time to time based on market conditions, stock price and other factors. Stryker has bought back shares worth roughly $410 million (as of December 7) under its existing $750 million repurchase program. The dividend increase ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/25/syk-stryker-increases-quarterly-dividend/61861/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Industry Outlook December 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379</link>
		<comments>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379#comments</comments>
		<pubDate>Tue, 07 Dec 2010 01:15:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Abiomed Inc]]></category>
		<category><![CDATA[ABMD]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>
		<category><![CDATA[ZOLL]]></category>
		<category><![CDATA[Zoll Medical Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=61379</guid>
		<description><![CDATA[Industry Dynamics The global medical devices industry is fairly large, intensely competitive and highly innovative with 2009 worldwide sales in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (“HCIT”). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, high unmet medical needs and increased incidence of lifestyle diseases (including cardiovascular diseases, diabetes, hypertension and obesity). Neuro, Orthopedic and Aesthetic represent the fastest growing categories. The aging population represents a major catalyst for demand of medical devices. The elderly population (persons 65 years and above) base in the U.S. registered 39.6 million in 2009, representing roughly 13% of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/06/mdt-medical-devices-industry-outlook-december-2010-industry-outlook/61379/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Third Quarter 2010 Outperforms &#8211; Raises View</title>
		<link>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948</link>
		<comments>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948#comments</comments>
		<pubDate>Thu, 18 Nov 2010 04:50:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=55948</guid>
		<description><![CDATA[Medical technology giant Stryker Corporation (SYK) reported strong third-quarter fiscal 2010 results with adjusted earnings per share of 80 cents beating the Zacks Consensus Estimate of 77 cents and surpassing the year-ago earnings of 69 cents. Adjusted earnings exclude one-time items such as gain on sale of the company’s orthopaedic implants manufacturing facility in France and tax adjustments. Healthy sales from the MedSurg Equipment business boosted net income, which catapulted 47.5% year-over-year to $338 million (or 85 cents a share). Adjusted net income rose 14.2% year-over-year to $317 million. The better-than-expected results coupled with the company’s upward guidance revision pushed up Stryker’s shares $2.68 (or 5.4%) to $52.75 in after-hours trading on October 19. Highlights from the Quarter Revenues Revenues grew 6.9% year-over-year to $1,768 million, ahead of the Zacks ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/17/syk-stryker-third-quarter-2010-outperforms-raises-view/55948/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Quarterly Earnings Beats &#8211; Profit Slides</title>
		<link>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042</link>
		<comments>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042#comments</comments>
		<pubDate>Wed, 03 Nov 2010 15:29:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=57042</guid>
		<description><![CDATA[Hanger Orthopedic (HGR) posted adjusted earnings per share of 37 cents for third quarter fiscal 2010, beating the Zacks Consensus Estimate of 35 cents and exceeding the year-ago earnings of 30 cents. The adjusted earnings exclude costs (of $8 million) associated with the relocation of the company’s corporate headquarters and charges (of $0.6 million) related to the recently announced acquisition of Nevada-based rehabilitation technologies provider Accelerated Care Plus (&#8220;ACP&#8221;). Net income slid 28% year-over-year to $6.9 million (or 21 cents a share) largely on account of the hefty relocation costs. Revenues &#38; Margins Net sales rose 7.5% year-over-year to $206.7 million, modestly trailing the Zacks Consensus Estimate of $207 million. Sales improved on the back of higher revenues from same-center at patient-care segment (up 4.1%), company’s distribution segments (up 10.5%) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/03/hgr-hanger-orthopedic-quarterly-earnings-beats-profit-slides/57042/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed&#8217;s Third Quarter Profit Rockets</title>
		<link>http://www.stockbloghub.com/2010/11/03/cnmd-conmeds-third-quarter-profit-rockets/57534</link>
		<comments>http://www.stockbloghub.com/2010/11/03/cnmd-conmeds-third-quarter-profit-rockets/57534#comments</comments>
		<pubDate>Wed, 03 Nov 2010 15:11:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=57534</guid>
		<description><![CDATA[Conmed Corporation (CNMD) reported third quarter fiscal 2010 adjusted (excluding restructuring charges) earnings per share of 34 cents, topping both the Zacks Consensus Estimate and the year-ago earnings of 28 cents. Restructuring expenses include consolidation of three New York manufacturing facilities and the cost of transferring product lines to the company’s new manufacturing plant in Chihuahua, Mexico. Net income skyrocketed to $8.8 million (or 31 cents a share), nearly a sevenfold growth year over year. Results were boosted by cost synergies from the company’s ongoing restructuring initiatives and improving hospital capital spending, which has rebounded from a slowdown last year. Revenues Revenues, however, fell 1.9% year over year to $172.2 million, below the Zacks Consensus Estimate of $176 million and the company’s guidance range of $174 million and $179 million. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/03/cnmd-conmeds-third-quarter-profit-rockets/57534/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Earnings Scorecard &#8211; Estimate Revisions</title>
		<link>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690</link>
		<comments>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690#comments</comments>
		<pubDate>Wed, 27 Oct 2010 00:50:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=56690</guid>
		<description><![CDATA[Third Quarter Revisited Medical technology giant Stryker Corp. (SYK) posted better-than-expected third quarter results with earnings of 80 cents per share exceeding the Zacks Consensus Estimate of 77 cents while net income rocketed 47.5% year-over-year led by sustained healthy sales from the MedSurg Equipment division. Revenues grew 6.9% year-over-year to $1,768 million, also beating the Zacks Consensus Estimate of $1,749 million. Stryker’s MedSurg business continues to show resilience in a still challenging macroeconomic backdrop. However, strong growth at MedSurg was partly marred by a yet another sluggish performance by the core Orthopedic division due to weak spine and knees sales. Stryker’s domestic sales benefited from higher shipments of orthopedic implants and surgical equipment while international revenue growth was muted on account of an unfavorable foreign exchange translation effect. Stryker raised ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/26/syk-stryker-earnings-scorecard-estimate-revisions/56690/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Third Quarter 2010 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595</link>
		<comments>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595#comments</comments>
		<pubDate>Tue, 19 Oct 2010 00:18:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Vision-Sciences Inc]]></category>
		<category><![CDATA[VSCI]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=55595</guid>
		<description><![CDATA[Orthopedic devices major Stryker Corporation (SYK) is slated to release its third-quarter fiscal 2010 results on Tuesday, October 19, 2010. Although the company has not released any official guidance for the third quarter, it envisages foreign currency exchange to drag net sales by 1% to 2% in the quarter. Despite concerns over its Orthopedic unit, Stryker remains confident about meeting its sales expectation for fiscal 2010. The current Zacks Consensus Estimate for third-quarter is 77 cents, representing an estimated 11.32% year-over-year growth. With respect to earnings surprise, Stryker has posted one positive surprise in the preceding four quarters while it met the Zacks Consensus Estimate on three other occasions. Second-Quarter Flashback Stryker reported second-quarter earnings per share of 80 cents matching the Zacks Consensus Estimate while surpassing the year-ago earnings ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/18/syk-stryker-third-quarter-2010-earnings-preview/55595/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243</link>
		<comments>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243#comments</comments>
		<pubDate>Wed, 25 Aug 2010 15:14:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WisdomTree SmallCap Dividend]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49243</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231</link>
		<comments>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231#comments</comments>
		<pubDate>Tue, 24 Aug 2010 22:53:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49231</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed&#8217;s Second Quarter Earnings Report Tops Expectations &#8211; Profit Soars</title>
		<link>http://www.stockbloghub.com/2010/08/01/cnmd-conmeds-second-quarter-earnings-report-tops-expectations-profit-soars/45384</link>
		<comments>http://www.stockbloghub.com/2010/08/01/cnmd-conmeds-second-quarter-earnings-report-tops-expectations-profit-soars/45384#comments</comments>
		<pubDate>Sun, 01 Aug 2010 17:43:34 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45384</guid>
		<description><![CDATA[Conmed Corporation (CNMD) reported second-quarter fiscal 2010 adjusted earnings per share of 32 cents, comfortably beating the Zacks Consensus Estimate of 26 cents while surpassing year-ago earnings of 17 cents. Restructuring expenses include costs of transferring product lines to the company&#8217;s new manufacturing facility in Chihuahua, Mexico. Net income sailed to $7.3 million (or 25 cents a share), representing an astounding five-fold year-over-year growth. Results were boosted by forecast-beating top-line growth and cost synergies from the company&#8217;s ongoing restructuring initiatives. Revenues Revenues soared 10% year over year to $181.1 million, well ahead of the Zacks Consensus Estimate of $177 million. Growth was fueled by healthy contributions from major business segments such as Arthroscopy (37% of sales), Powered Surgical (20%) and Electrosurgery (14%). Arthroscopy revenues increased 21.6% year over year to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/01/cnmd-conmeds-second-quarter-earnings-report-tops-expectations-profit-soars/45384/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932</link>
		<comments>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932#comments</comments>
		<pubDate>Tue, 27 Jul 2010 13:25:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=44932</guid>
		<description><![CDATA[Second Quarter Revisited Medical devices giant Stryker Corp. (SYK) produced a mixed bag in the second quarter, matching earnings expectations while missing on the revenue front. Earnings of 80 cents per share came in line with the Zacks Consensus Estimate and net income leapt 9.5% year-over-year, led by healthy growth at the MedSurg Equipment division. Revenues grew 7.6% year-over-year to $1,758 million, but trailed the Zacks Consensus Estimate of $1,767 million as higher sales from MedSurg were marred by a sluggish Orthopedic business. International revenue growth was muted by lower Orthopedic Implants shipments, discontinued product lines, termination of distributor contracts. Lower-than-expected sales hit Stryker’s shares which slipped $1.79 (or 3.49%) in after-market trading on July 20. Agreement of Analysts The overall trend in estimate revisions for fiscal 2010 is inclined ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/27/syk-stryker-earnings-scorecard/44932/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Analyst Maintains Outperform</title>
		<link>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151</link>
		<comments>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151#comments</comments>
		<pubDate>Mon, 24 May 2010 20:51:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38151</guid>
		<description><![CDATA[We reiterate our ‘Outperform’ rating on Hanger Orthopedic Group, Inc. (HGR) with a target price of $21 based on a P/E of 16.4x our fiscal 2010 EPS estimate of $1.28. The company’s results for the first quarter fiscal 2010 were outstanding with growth witnessed across all parameters. Hanger reported first quarter fiscal 2010 earnings per share of 16 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 14 cents. Net sales for the first quarter increased 5.4% year-over-year to $178.3 million. Growth can be primarily attributed to higher same-center sales at patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services and distribution segments contributed 87.5% and 12.2% to total sales, respectively. In terms of payor mix: Commercial and other, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/24/hgr-hanger-orthopedic-group-analyst-maintains-outperform/38151/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Resolves FDA Warning Letters</title>
		<link>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948</link>
		<comments>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948#comments</comments>
		<pubDate>Fri, 21 May 2010 16:19:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMF]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[iShares S&P California Municipal Bond]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=37948</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently resolved two warning letters issued by the U.S. Food and Drug Administration (FDA). The FDA has given a clean certificate to Stryker after it found that the actions undertaken by the company to address issues raised in these letters were sufficient. In 2007, Stryker received a warning letter from the FDA regarding compliance issues with regard to certain quality system requirements at its reconstructive implant manufacturing facility in Cork, Ireland. In 2009, Stryker received another warning letter from the FDA related to compliance issues for one of its craniomaxillofacial (CMF) implant products. These products were sold through the company’s CMF distribution facility in Portage, Michigan. Stryker took corrective actions at both its Cork and CMF facilities. The FDA has informed Stryker that no further formal corrective ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/21/syk-stryker-resolves-fda-warning-letters/37948/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDT) Medical Devices Stock Review &#8211; May 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750</link>
		<comments>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750#comments</comments>
		<pubDate>Tue, 11 May 2010 21:55:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[OMCL]]></category>
		<category><![CDATA[Omnicell Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=36750</guid>
		<description><![CDATA[The global medical devices industry is fairly large, with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices, Healthcare IT, etc. We recommend companies providing life-sustaining products to investors in the medical devices space. These companies provide a strong recurring stream of revenues as patients are unable to forego these products due to their life-sustaining nature. Furthermore, investors should allocate funds to companies with high-earnings-quality profiles. Large companies with a wide portfolio of products are also better poised for improved returns. These companies have a greater capability of withstanding a downturn in the economy. We advise investors to avoid companies that have grown historically through ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/11/mdt-medical-devices-stock-review-may-2010-industry-outlook/36750/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Reports Earnings In Line With Expectations</title>
		<link>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453</link>
		<comments>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453#comments</comments>
		<pubDate>Thu, 29 Apr 2010 14:15:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=35453</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) reported first quarter fiscal 2010 earnings per share of 16 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 14 cents. Sales Net sales for the first quarter increased 5.4% year over year to $178.3 million. Growth can be primarily attributed to higher same-center sales at patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services and distribution segments contributed 87.5% and 12.2% to total sales, respectively. In terms of payor mix: Commercial and other, Medicare, Medicaid and VA contributed 59.4%, 28.3%, 6.8% and 5.5% to total revenues, respectively. Margins Hanger witnessed an expansion in margins in the first quarter. Gross margin increased 10 basis points (bps) year over year to 69.9%. Excluding the office ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/29/hgr-hanger-orthopedic-group-reports-earnings-in-line-with-expectations/35453/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Beats Consensus Estimate</title>
		<link>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480</link>
		<comments>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480#comments</comments>
		<pubDate>Wed, 21 Apr 2010 15:28:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=34480</guid>
		<description><![CDATA[Stryker Corporation (SYK) reported results for the first quarter of fiscal 2010. Earnings per share were 80 cents, surpassing the Zacks Consensus Estimate of 78 cents and the year-ago earnings of 71 cents. Sales Total revenues in the first quarter increased 12.4% year over year to $1,799.1 million. Excluding a favorable foreign currency translation (FX), net sales increased 8.7% year over year. Growth was witnessed across both the business segments. Orthopedic Implants sales increased 10.7% year over year to $1,076.9 million. Growth was led by strong demand for the company’s Hips, Knees, Trauma and Spine products. MedSurg Equipment sales increased 15.0% year over year to $722.2 million. Growth can be attributed to higher sales of Surgical equipment and surgical navigation systems, Endoscopic and communications systems, and Patient handling and emergency ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/21/syk-stryker-beats-consensus-estimate/34480/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Analyst Maintains Stock at Neutral</title>
		<link>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199</link>
		<comments>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199#comments</comments>
		<pubDate>Thu, 08 Apr 2010 21:15:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33199</guid>
		<description><![CDATA[We recently assigned a ‘Neutral’ rating to Stryker Corporation (SYK) with a target price of $60 based on a P/E of 18.4x our fiscal 2010 EPS estimate of $3.26. Stryker reported fourth quarter earnings per share of 82 cents, in line with the Zacks Consensus Estimate and higher than the year-ago figure of 74 cents. For fiscal 2009, earnings per share of $2.95 surpassed the year-ago figure of $2.83. Total revenues increased 6.8% year over year to $1,834.2 million in the fourth quarter. Excluding a favorable foreign currency (FX) translation, net sales increased 2.5% year over year. In terms of business segments: Orthopedic Implants sales increased 9.7% year over year to $1,115.6 million. Growth was led by strong demand for the company’s Hips, Knees, Trauma, Spine and Craniomaxillofacial products. MedSurg ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/08/syk-stryker-analyst-maintains-stock-at-neutral/33199/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Gets Good News From FDA</title>
		<link>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707</link>
		<comments>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707#comments</comments>
		<pubDate>Fri, 26 Mar 2010 00:30:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31707</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently received a clean bill from the U.S. Food and Drug Administration (FDA), the latter declaring that the actions undertaken by the company to address the issues raised in a 2007 warning letter are sufficient. No further formal corrective actions are required by the company. In 2007, the FDA had issued a warning letter to Stryker regarding compliance with certain quality system requirements at the company’s reconstructive implant manufacturing facility in Mahwah, New Jersey. The resolution of the warning letter indicates Stryker’s focus on improving quality systems throughout its organization. Stryker is one of the world’s largest medical devices companies operating in the global orthopedic market. In the orthopedic space, Stryker faces competition from major players like Zimmer Holdings Inc. (ZMH), CONMED Corporation (CNMD), Smith &#38; Nephew (SNN), ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/25/syk-stryker-corporation-gets-good-news-from-fda/31707/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) CONMED Analysts Maintain Neutral Rating</title>
		<link>http://www.stockbloghub.com/2010/03/12/cnmd-conmed-analysts-maintain-neutral-rating/30484</link>
		<comments>http://www.stockbloghub.com/2010/03/12/cnmd-conmed-analysts-maintain-neutral-rating/30484#comments</comments>
		<pubDate>Fri, 12 Mar 2010 18:33:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30484</guid>
		<description><![CDATA[We recently maintained our Neutral rating on CONMED Corporation (CNMD) with a target price of $24 based on a P/E of roughly 19.4x our fiscal 2010 EPS estimate of $1.24. CONMED Corporation reported fourth quarter fiscal 2009 earnings per share of 37 cents, surpassing the Zacks Consensus Estimate of 32 cents and the year-ago earnings of 34 cents. In fiscal 2009, earnings per share were $1.00, lower than the year-ago earnings of $1.54. Total sales in the fourth quarter increased 6.4% year over year to $190.6 million. Growth was registered across all major business segments. Arthroscopy sales increased 8.0% year over year to $75.7 million. Powered Surgical Instruments sales increased 10.4% year over year to $40.4 million. Electrosurgery sales increased 6.6% year over year to $25.9 million. Single-use and reposable ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/12/cnmd-conmed-analysts-maintain-neutral-rating/30484/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Beats Consensus Estimates</title>
		<link>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243</link>
		<comments>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243#comments</comments>
		<pubDate>Wed, 17 Feb 2010 22:48:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28243</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 37 cents, beating the Zacks Consensus Estimate of 36 cents and the year-ago earnings of 26 cents. For fiscal 2009, earnings per share were $1.13, higher than the year-ago earnings of 86 cents. Quarterly results Net sales for the fourth quarter increased 10.6% year over year to $205.1 million. Growth can be primarily attributed to higher same-center sales of patient care centers, higher demand for the company’s distribution segment and acquisitions. Hanger witnessed an expansion in margins in the fourth quarter. Gross margin increased 60 basis points (bps) year over year to 71.0%. Operating margin increased 160 bps year over year to 13.4%. Fiscal year results Total revenues in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/17/hgr-hanger-orthopedic-group-beats-consensus-estimates/28243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed Corporation Surpasses Earnings Estimates</title>
		<link>http://www.stockbloghub.com/2010/02/08/cnmd-conmed-corporation-surpasses-earnings-estimates-2/27327</link>
		<comments>http://www.stockbloghub.com/2010/02/08/cnmd-conmed-corporation-surpasses-earnings-estimates-2/27327#comments</comments>
		<pubDate>Mon, 08 Feb 2010 18:10:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=27327</guid>
		<description><![CDATA[Conmed Corporation (CNMD) reported fourth quarter and full fiscal 2009 results. For the quarter, earnings per share were 37 cents, surpassing the Zacks Consensus Estimate of 32 cents and the year-ago earnings of 34 cents. In fiscal 2009, earnings per share were $1.00, lower than the year-ago earnings of $1.54. Quarterly results Total sales in the fourth quarter increased 6.4% year over year to $190.6 million. Growth was registered across all major business segments. Arthroscopy sales increased 8.0% year over year to $75.7 million. Powered Surgical Instruments sales increased 10.4% year over year to $40.4 million. Electrosurgery sales increased 6.6% year over year to $25.9 million. Single-use and reposable revenues increased 5.8% year over year to $141.3 million. Capital equipment sales increased 7.9% year over year to $49.3 million. Gross ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/08/cnmd-conmed-corporation-surpasses-earnings-estimates-2/27327/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDRX) Medical Devices Stock Review &#8211; Feburary 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/02/01/mdrx-medical-devices-stock-review-feburary-2010-industry-outlook/26636</link>
		<comments>http://www.stockbloghub.com/2010/02/01/mdrx-medical-devices-stock-review-feburary-2010-industry-outlook/26636#comments</comments>
		<pubDate>Mon, 01 Feb 2010 22:23:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare Information Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[OMCL]]></category>
		<category><![CDATA[Omnicell Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26636</guid>
		<description><![CDATA[The global medical devices industry is fairly large, with annual worldwide sales in excess of $200 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices, Healthcare IT, etc. We recommend companies providing life-sustaining products to investors in the medical devices space. These companies provide a strong recurring stream of revenues as patients are unable to forego these products due to their life-sustaining nature. Furthermore, investors should allocate funds to companies with high-earnings-quality profiles. Large companies with a wide portfolio of products are also better poised for improved returns. These companies have a greater capability of withstanding a downturn in the economy. Another area which is interestingly poised for growth these days is Healthcare IT. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/01/mdrx-medical-devices-stock-review-feburary-2010-industry-outlook/26636/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Reports Preliminary Results</title>
		<link>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968</link>
		<comments>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968#comments</comments>
		<pubDate>Thu, 14 Jan 2010 19:19:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24968</guid>
		<description><![CDATA[Stryker Corporation (SYK) reported preliminary revenue results for the fourth quarter and full fiscal 2009. For the fourth quarter, net sales were $1,834 million, an increase of 6.8% year over year. Excluding a favorable foreign currency translation (FX), net sales increased 2.5% year over year. For full fiscal 2009, net sales were $6,723 million, an increase of 0.1% year over year. Excluding an unfavorable FX, net sales increased 1.7% year over year. Stryker will report full fourth quarter and fiscal 2009 results on Jan 26, 2010 after the market closes. In terms of business segments: Orthopedic Implants sales increased 9.7% year over year to $1,116 million in the fourth quarter of 2009. MedSurg Equipment sales increased 2.5% year over year to $719 million in the reported quarter. In fiscal 2009, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/14/syk-stryker-corporation-reports-preliminary-results/24968/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Completes Acquisition of Ascent Healthcare Solutions</title>
		<link>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078</link>
		<comments>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078#comments</comments>
		<pubDate>Mon, 04 Jan 2010 17:55:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24078</guid>
		<description><![CDATA[Stryker Corporation (SYK) recently completed the acquisition of Ascent Healthcare Solutions, the market leader in the reprocessing and remanufacturing of medical devices in the U.S. The acquisition will be neutral to Stryker’s earnings per share in 2010 and accretive thereafter. Post-acquisition, Ascent Healthcare Solutions has become a division of Stryker under the company’s MedSurg group of businesses and has retained its name. Ascent Healthcare Solutions Inc. was formed in 2005 by the merger of Alliance Medical Corporation and Vanguard Medical Concepts. These two were the leading players in the reprocessing and remanufacturing of medical devices. Ascent Healthcare Solutions Inc. provides its services to 1,800 leading hospitals and numerous Group Purchasing Organizations (GPOs) throughout North America. The company has two state-of-the-art reprocessing facilities in Phoenix, Arizona and Lakeland, Florida. Ascent Healthcare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/04/syk-stryker-completes-acquisition-of-ascent-healthcare-solutions/24078/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker&#8217;s Announces New Share Repurchases</title>
		<link>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510</link>
		<comments>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510#comments</comments>
		<pubDate>Thu, 10 Dec 2009 21:19:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22510</guid>
		<description><![CDATA[Stryker Corp. (SYK) recently announced that share repurchases of up to $750 million has been authorized by its Board of Directors. The manner, timing and amount of any purchases will depend on market conditions, stock price and other factors and will be subject to regulatory considerations. Share repurchases can be made from the open market and in privately negotiated transactions. Stryker had a strong cash, cash equivalents and short-term investments of roughly $2.9 billion at the end of the third quarter of 2009. The company may make use of this cash for repurchases of shares. Stryker had 397.7 million shares outstanding as of Oct 31, 2009. Stryker’s Board of Directors also declared a quarterly dividend of 15 cents per share. The dividend is payable on Jan 29, 2010 to shareholders ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/10/syk-strykers-announces-new-share-repurchases/22510/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>($SYK) Stryker Corporation Set for Acquisition</title>
		<link>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642</link>
		<comments>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642#comments</comments>
		<pubDate>Tue, 01 Dec 2009 23:44:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=21642</guid>
		<description><![CDATA[Stryker Corporation (SYK) is set to acquire privately-held Ascent Healthcare Solutions Inc., the market leader in the reprocessing and remanufacturing of medical devices in the U.S. The all-cash transaction is valued at $525 million. The acquisition is expected to close by the end of 2009. It will be neutral to Stryker&#8217;s earnings per share in 2010 and accretive thereafter. Post-acquisition, Ascent Healthcare Solutions will become a division of Stryker under the company’s MedSurg group of businesses and will retain its name. Ascent Healthcare Solutions Inc. was formed in 2005 by the merger of Alliance Medical Corporation and Vanguard Medical Concepts. These two were the leading players in the reprocessing and remanufacturing of medical devices. Ascent Healthcare Solutions Inc. presently provides its services to 1,800 leading hospitals and numerous Group Purchasing ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/01/syk-stryker-corporation-set-for-acquisition/21642/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Strikes Acquisition Deals</title>
		<link>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474</link>
		<comments>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474#comments</comments>
		<pubDate>Sat, 14 Nov 2009 22:45:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SURG]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Synergetics USA Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20474</guid>
		<description><![CDATA[Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million in upfront payment as well as potential future milestone and royalty payments of up to $36 million. These acquisitions are expected to be completed by the end of 2009. OtisMed Corp. is a privately held software technology firm that focuses on customizable instrumentation complementing Stryker’s Triathlon Knee System, as well as other Stryker implants. Stryker will incorporate OtisMed as part of its Orthopaedics division. Mutoh Co. Ltd. is a Japanese company and a leading provider of equipment, products, instruments and services to the medical and scientific communities. On the other hand, Synergetics USA, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/14/syk-stryker-corporation-strikes-acquisition-deals/20474/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed Corporation Surpasses Earnings Estimates</title>
		<link>http://www.stockbloghub.com/2009/10/27/cnmd-conmed-corporation-surpasses-earnings-estimates/18910</link>
		<comments>http://www.stockbloghub.com/2009/10/27/cnmd-conmed-corporation-surpasses-earnings-estimates/18910#comments</comments>
		<pubDate>Wed, 28 Oct 2009 03:26:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18910</guid>
		<description><![CDATA[Conmed Corporation (CNMD) reported third quarter 2009 earnings per share of 28 cents, surpassing the Zacks Consensus Estimate of 17 cents. However, earnings per share were lower than the year-ago earnings of 37 cents. Sales Net sales for the reported quarter were $175.5 million, declining roughly 2.2% year over year. Excluding an unfavorable foreign currency translation (FX), net sales increased marginally by 0.4% year over year. Single-use and reposable sales contributed roughly 75% to total sales and declined 0.4% year over year. Capital equipment sales contributed the balance and declined 7.1% year over year. The decline in net sales can be primarily attributed to the current economic turbulence that resulted in patients deferring their elective procedures. The decline was broad-based across major products. Arthroscopy sales declined 1.2% year over year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/27/cnmd-conmed-corporation-surpasses-earnings-estimates/18910/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HGR) Hanger Orthopedic Group Beats Earnings Consensus</title>
		<link>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953</link>
		<comments>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953#comments</comments>
		<pubDate>Wed, 28 Oct 2009 01:23:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Specialized Health Services]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[EXAC]]></category>
		<category><![CDATA[Exactech Inc]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[OFIX]]></category>
		<category><![CDATA[OMI]]></category>
		<category><![CDATA[Orthofix International NV]]></category>
		<category><![CDATA[Owens & Minor Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18953</guid>
		<description><![CDATA[Hanger Orthopedic Group, Inc. (HGR) yesterday reported financial results for the third quarter of fiscal 2009 after market close. Earnings per share were 30 cents, beating the Zacks Consensus Estimate of 27 cents and the year-ago earnings of 23 cents. Sales Net sales for the quarter increased 7.6% year over year to $192.3 million. Growth can be primarily attributed to higher same-center sales of patient care centers, higher demand for the company’s distribution segment and acquisitions. Patient-care services contributed approximately 88% to total sales while the remaining came from the distribution segment. Margins Gross margin declined 70 basis points (bps) year over year to 69.4% in the reported quarter due to higher cost of raw materials. However, strong sales and the company’s expense management initiatives helped it to increase operating ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/27/hgr-hanger-orthopedic-group-beats-earnings-consensus/18953/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) CONMED Corporation &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-3/18361</link>
		<comments>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-3/18361#comments</comments>
		<pubDate>Wed, 21 Oct 2009 23:36:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18361</guid>
		<description><![CDATA[Conmed Corp. (CNMD) operates in highly competitive markets against competitors that are much larger, technically competent and possess substantially more assets. Additionally, many of these competitors offer a range of products not matched by Conmed, which may make Conmed&#8217;s offerings less attractive to surgeons, hospitals, and group purchasing organizations that are trying to reduce the number of vendors they do business with. In the second quarter, earnings per share were $0.17, compared to the Zacks Consensus Estimate of $0.16 and the year-ago earnings of $0.43. We have an Underperform rating on Conmed with a target price of $18. Zacks Investment Research View original at: Zacks.com News Feed]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-3/18361/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SYK) Stryker Corporation Meets Earnings Expectations</title>
		<link>http://www.stockbloghub.com/2009/10/21/syk-stryker-corporation-meets-earnings-expectations/18372</link>
		<comments>http://www.stockbloghub.com/2009/10/21/syk-stryker-corporation-meets-earnings-expectations/18372#comments</comments>
		<pubDate>Wed, 21 Oct 2009 22:28:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Smith & Nephew Plc]]></category>
		<category><![CDATA[SNN]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18372</guid>
		<description><![CDATA[Stryker Corporation (SYK) yesterday reported third quarter earnings per share of 69 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 66 cents. Net sales were flat year over year at approximately $1.7 billion. An unfavorable foreign exchange translation (FX) negatively affected net sales in the quarter. Excluding FX, net sales increased 1.2% year over year. On a geographic basis, U.S. sales contributed roughly 65% of total sales and increased 0.2% year over year. International sales declined 0.3% year over year. In terms of business segments: Orthopaedic Implants sales increased 5.5% year over year to $1.0 billion. Growth was contributed by all the products, such as Hips, Knees, Trauma, Spine, and Craniomaxillofacial. MedSurg Equipment sales declined 7.7% year over year to $637 million. The decline ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/21/syk-stryker-corporation-meets-earnings-expectations/18372/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) CONMED Corporation &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-2/18323</link>
		<comments>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-2/18323#comments</comments>
		<pubDate>Wed, 21 Oct 2009 16:52:40 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18323</guid>
		<description><![CDATA[Conmed Corp. (CNMD) operates in highly competitive markets against competitors that are much larger, technically competent and possess substantially more assets. Additionally, many of these competitors offer a range of products not matched by Conmed, which may make Conmed&#8217;s offerings less attractive to surgeons, hospitals, and group purchasing organizations that are trying to reduce the number of vendors they do business with. In the second quarter, earnings per share were $0.17, compared to the Zacks Consensus Estimate of $0.16 and the year-ago earnings of $0.43. We have an Underperform rating on Conmed with a target price of $18. Zacks Investment Research View original at: Zacks.com News Feed]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/21/cnmd-conmed-corporation-bear-of-the-day-2/18323/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CNMD) Conmed Corporation &#8211; Bear of the Day</title>
		<link>http://www.stockbloghub.com/2009/10/16/cnmd-conmed-corporation-bear-of-the-day/17736</link>
		<comments>http://www.stockbloghub.com/2009/10/16/cnmd-conmed-corporation-bear-of-the-day/17736#comments</comments>
		<pubDate>Sat, 17 Oct 2009 00:58:38 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17736</guid>
		<description><![CDATA[Conmed (CNMD) operates in highly competitive markets against competitors that are much larger, technically competent and possess substantially more assets. Additionally, many of these competitors offer a range of products not matched by Conmed, which may make Conmed&#8217;s offerings less attractive to surgeons, hospitals and group purchasing organizations that are trying to reduce the number of vendors they do business with. In the second quarter, earnings per share were 17 cents, compared to the Zacks Consensus Estimate of 16 cents and the year-ago earnings of 43 cents. We have an Underperform rating on Conmed with a target price of $18. Zacks Investment Research View original at: Zacks.com News Feed]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/16/cnmd-conmed-corporation-bear-of-the-day/17736/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MDRX) Medical Devices &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2009/10/16/mdrx-medical-devices-industry-outlook/17835</link>
		<comments>http://www.stockbloghub.com/2009/10/16/mdrx-medical-devices-industry-outlook/17835#comments</comments>
		<pubDate>Fri, 16 Oct 2009 20:38:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare Information Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Dickinson And Company]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category><![CDATA[HGR]]></category>
		<category><![CDATA[Intuitive Surgical Inc]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Merge Healthcare Incorporated.]]></category>
		<category><![CDATA[MRGE]]></category>
		<category><![CDATA[OMCL]]></category>
		<category><![CDATA[Omnicell Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17835</guid>
		<description><![CDATA[The global medical devices industry is fairly large and is valued at roughly $223 billion, with the U.S. accounting for approximately 41%. The industry is divided into different categories such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT. In the medical devices space, we recommend that investors focus on companies providing life-sustaining products. These companies provide a strong recurring stream of revenues as patients are unable to forego these products. Furthermore, investors should allocate funds to companies with high-earnings-quality profiles. Large companies with a wide portfolio of products are also better poised for good returns. These companies are capable of withstanding the current economic recession. Another area which is interestingly poised for growth these days is Healthcare IT. The landscape has changed since the Obama Administration passed a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/16/mdrx-medical-devices-industry-outlook/17835/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

